CLASS II Drug recall · Reported 2 Mar 2022 · FDA Enforcement Report

Maximum Strength Plus Menthol No Drip Nasal Spray recalled

Perrigo Company is recalling Maximum Strength Plus Menthol No Drip Nasal Spray, Oxymetazoline HCl 05% Nasal, distributed nationwide in the US. The recall was initiated on 26 Oct 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch: 1FK1251, Exp 02/28/2023; 1BK0716, Exp 12/31/2022
NDC72288-703
Quantity recalled37,104 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0603-2022
FDA event ID
88905
Recalling firm
Perrigo Company, Allegan, MI
Manufacturer
Amazon.com Services LLC
Classification
Class II
Status
Terminated
Recall initiated
26 Oct 2021
FDA classified
23 Feb 2022
Reported
2 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Drug class
Nasal Sprays

Timeline

26 Oct 2021Recall initiated by company
23 Feb 2022Classified by FDA+120 days
2 Mar 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Product as listed by the FDA

Maximum Strength Plus Menthol No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: AMAZON.COM SERVICES LLC 410 TERRY AVENUE N.SEATTLE, WA 98109. NDC: 72288-703-10

Where it was distributed

Nationwide in the USA

Nationwide

Stores named: Amazon

Questions about this recall

Is Maximum Strength Plus Menthol No Drip Nasal Spray, Oxymetazoline HCl 05% Nasal recalled?

Yes. Perrigo Company recalled Maximum Strength Plus Menthol No Drip Nasal Spray, Oxymetazoline HCl 05% Nasal on 26 Oct 2021. The recall is Class II and its status is Terminated. Recall number D-0603-2022.

Why was it recalled?

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Which lots are affected?

Batch: 1FK1251, Exp 02/28/2023; 1BK0716, Exp 12/31/2022

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Perrigo Company

All 106

Other Oxymetazoline recalls

All 27